Daily News Podcast

Valsartan cancer risk is low

Publish date: July 31, 2018

 

The FDA says that cancer risk associated with NDMA contained in impure valsartan is definitely real, but it is very low. Also today, drinking during pregnancy could impact cognition, sexual function counseling should start early, and those with HIV develop more frailty. Listen to the MDedge Daily News for today’s top news.

Recommended Reading

Too many antibiotics prescribed in urgent care
MDedge Rheumatology
Managing HIV with diabetes
MDedge Rheumatology
Telemedicine payment expansion?
MDedge Rheumatology
Bundle pay plan didn’t save money
MDedge Rheumatology
Brain damage, slight benefit seen in epinephrine cardiac arrest
MDedge Rheumatology
Is fibromyalgia one disorder – or two?
MDedge Rheumatology
Is fish oil’s heart benefit a fish tale?
MDedge Rheumatology
Blood pressure meds cut cognitive impairment risk
MDedge Rheumatology
Antibody cleared amyloid plaques, slowed cognitive decline
MDedge Rheumatology
Free skin cancer screening highlights need
MDedge Rheumatology